Cargando...

Belimumab Alters Transitional B Cell Subset Proportions in Stable Systemic Lupus Erythematosus Patients

OBJECTIVE: We evaluated the effects of the BAFF targeting antibody, Belimumab, on human nonmemory B cell pools. Human B cell pools were identified using surface markers adapted from mouse studies that specifically assessed reductions in immature B cells due to BAFF-depletion. SLE patients have high...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Lupus
Autores principales: Benitez, Abigail, Torralba, Karina, Ngo, Michelle, Salto, Lorena M., Choi, Kristal S., De Vera, Michael E., Payne, Kimberly J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769209/
https://ncbi.nlm.nih.gov/pubmed/31423896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203319869468
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!